Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance on Long Term Drug Use of JARDIANCE® Tablets in Patients With Chronic Heart Failure in Japan

NCT05262764 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT05262764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05262764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance on Long Term Drug Use of JARDIANCE® Tablets in Patients With Chronic Heart Failure in Japan
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
April 15, 2022
Completion date
June 28, 2024
Enrollment
1,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure